Oslo, Norway

Terje Thomassen



Average Co-Inventor Count = 5.3

ph-index = 3

Forward Citations = 65(Granted Patents)


Company Filing History:


Years Active: 1993-1996

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Terje Thomassen: Innovator in Chelating Agents

Introduction

Terje Thomassen is a notable inventor based in Oslo, Norway. He has made significant contributions to the field of chelating agents, particularly in applications related to medical imaging and detoxification. With a total of 3 patents, his work has had a profound impact on diagnostic and therapeutic technologies.

Latest Patents

Thomassen's latest patents include innovative compounds that serve as chelating agents. One of his patents focuses on Aminopolycarboxylic acids and derivatives thereof, which are particularly useful for the preparation of diagnostic and therapeutic agents for magnetic resonance imaging, scintigraphy, ultrasound imaging, radiotherapy, and heavy metal detoxification. Another patent also centers on Aminopolycarboxylic acids and derivatives for magnetic resonance, emphasizing their utility in similar medical applications.

Career Highlights

Throughout his career, Terje Thomassen has worked with prominent companies in the healthcare sector. Notably, he has been associated with Nycomed Imaging AS and GE Healthcare AS, where he has contributed to advancements in medical imaging technologies. His expertise in chelating agents has positioned him as a key figure in the development of innovative solutions for healthcare.

Collaborations

Some of his notable coworkers include Arne Berg and Torsten Almen, who have collaborated with him on various projects related to his patents and innovations.

Conclusion

Terje Thomassen's contributions to the field of chelating agents and medical imaging are commendable. His patents reflect a commitment to advancing healthcare technologies, making him a significant figure in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…